You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

LISINOPRIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lisinopril patents expire, and what generic alternatives are available?

Lisinopril is a drug marketed by Accord Hlthcare, Ascent Pharms Inc, Aurobindo, Chartwell Rx, Corepharma, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Prinston Inc, Rising, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt Bio Ag, Epic Pharma Llc, Mylan, and Sandoz. and is included in thirty-two NDAs.

The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Drug patent expirations by year for LISINOPRIL
Drug Prices for LISINOPRIL

See drug prices for LISINOPRIL

Drug Sales Revenue Trends for LISINOPRIL

See drug sales revenues for LISINOPRIL

Recent Clinical Trials for LISINOPRIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of RochesterEarly Phase 1
Medical College of WisconsinEarly Phase 1
Wake Forest University Health SciencesPhase 4

See all LISINOPRIL clinical trials

Pharmacology for LISINOPRIL
Medical Subject Heading (MeSH) Categories for LISINOPRIL
Paragraph IV (Patent) Challenges for LISINOPRIL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
QBRELIS Oral Solution lisinopril 1 mg/mL 208401 1 2019-10-24

US Patents and Regulatory Information for LISINOPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising LISINOPRIL lisinopril TABLET;ORAL 075999-006 Jul 1, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs LISINOPRIL lisinopril TABLET;ORAL 076059-005 Jul 1, 2002 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma Intl Pharms LISINOPRIL lisinopril TABLET;ORAL 076063-006 Jun 27, 2003 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.